Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#1861
ANI Pharmaceuticals, Inc.
73.900
0
-2.95%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-2.95%
Monthly Change
-7.56%
6 month change
-21.91%
Cambio anual
-21.91%
Cierres anteriores
76.145
0
Open
73.900
0
Bid
Ask
Low
73.900
0
High
73.900
0
Volumen
73
Markets
Acciones
Atención Sanitaria
ANIP
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
—
Valuation ratios
Enterprise value
1.07 B
2.29 B
2.05 B
3.4 B
3.47 B
3.25 B
17.4 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
-100.58
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
—
—
Price to cash flow ratio
22.76
174.72
20.86
8.75
16.68
9.05
45.65
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
5.7
Enterprise value to EBITDA ratio
23.96
68.32
21.63
19.62
7.92
—
—
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.06
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.16
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.73
34
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
246.07
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
49.84
EBITDA margin %
21.41
15.49
30.02
35.55
71.25
30
140.79
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
34.81
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
8.17
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
10.49
Inventory turnover
—
1.41
1.48
1.68
2.02
2.44
2.42
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.65
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.87
Long term debt to total equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
2.55
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9
EBIT per share
-0
-1.09
-1.57
2.72
15.61
3.81
3.85
EBITDA per share
3.73
2.66
5.84
9.51
22.66
12.48
15.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
44.1
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
125.02
Tangible book value per share
0.3
0.94
2.08
10.75
-10.26
-0.06
-18.84
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
77.36
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
91.84
Noticias
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
ANI Pharma T4 2025: cambio hacia enfermedades raras impulsa crecimiento de ingresos del 44%
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
ANI Pharma superaron 0.36$ las previsiones de BPA en el cuarto trimestre del año
ANI Pharma supera por 0,36$ las previsiones de BPA en el cuarto trimestre del año
ANI Pharma earnings beat by $0.36, revenue topped estimates
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
ANI Pharmaceuticals presentará resultados con Cortrophin impulsando el cambio